Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1,4,7,10-dota
2. 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic Acid
3. 1,4,7,10-tetraazacyclododecane--n,n',n'',n'''-tetraacetic Acid
4. 1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane
5. 2,2',2'',2'''-(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetryl)tetraacetic Acid
6. Cudota
7. Dota
8. Dota Acid
1. Dota
2. 60239-18-1
3. 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic Acid
4. Dota Acid
5. 1,4,7,10-dota
6. 2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetic Acid
7. 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetic Acid
8. Chebi:61028
9. Dot-a
10. Mfcd00068657
11. Nsc-681107
12. 1hte449dgz
13. Mls001333612
14. Tetraxetan (usan)
15. Nsc681107
16. 2,2',2'',2'''-(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayl)tetraacetic Acid
17. 2,2',2',2'''-(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetryl)tetraacetic Acid
18. Smr000857276
19. Tetraxetan [usan]
20. Unii-1hte449dgz
21. Tetraxetanum
22. Gadoterate-meglumine
23. 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic-acid
24. Nsc 681107
25. Gadobutrol Impurity 9
26. Tetraxetan [inn]
27. Tetraxetan [usan:inn]
28. Dota [mi]
29. Epitope Id:146095
30. Tetraxetan [usp-rs]
31. Schembl18018
32. Cid_121841
33. Gtpl5538
34. Chembl1721515
35. Bdbm88700
36. Amy5853
37. Dtxsid60208984
38. Hms2236n04
39. Hms3373h02
40. Tetraxetan [usp Monograph]
41. Bcp13075
42. Zinc22059268
43. Akos015854210
44. Ncgc00246979-01
45. Ac-31772
46. As-19566
47. Nci60_028933
48. Sy057414
49. 3-(dimethyloctadecylammonio)propanesulfonate
50. Cs-0046228
51. Ft-0606756
52. T1875
53. D06092
54. F16414
55. A851290
56. Q161515
57. J-650232
58. 1,4,7,10-tetraazacylododeane-1,4,7,10-tetraacetic Acid
59. 1,4,7,10-tetraazacyclododecane N,n',n",n'"-tetraacetic Acid
60. 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic Acid
61. 1,4,7,10-tetraazacyclododecane-n,n',n', N'''-tetraacetic Acid
62. 1,4,7,10-tetraazacyclododecane-n,n'n'',n'''-tetraacetic Acid
63. 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic Acid, >=97.0% (chn)
64. 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetic Acid, Min. 98% Dota
65. 2,2',2'',2'''-(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetryl)tetraacetic Acid
66. 2-[4,7,10-tris(2-hydroxy-2-oxoethyl)-1,4,7,10-tetrazacyclododec-1-yl]ethanoic Acid
67. 2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecan-1-yl]acetic Acid
| Molecular Weight | 404.42 g/mol |
|---|---|
| Molecular Formula | C16H28N4O8 |
| XLogP3 | -10.6 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 12 |
| Rotatable Bond Count | 8 |
| Exact Mass | 404.19071386 g/mol |
| Monoisotopic Mass | 404.19071386 g/mol |
| Topological Polar Surface Area | 162 Ų |
| Heavy Atom Count | 28 |
| Formal Charge | 0 |
| Complexity | 447 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Chelating Agents
Chemicals that bind to and remove ions from solutions. Many chelating agents function through the formation of COORDINATION COMPLEXES with METALS. (See all compounds classified as Chelating Agents.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A DOTA manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of DOTA, including repackagers and relabelers. The FDA regulates DOTA manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. DOTA API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of DOTA manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A DOTA supplier is an individual or a company that provides DOTA active pharmaceutical ingredient (API) or DOTA finished formulations upon request. The DOTA suppliers may include DOTA API manufacturers, exporters, distributors and traders.
click here to find a list of DOTA suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A DOTA DMF (Drug Master File) is a document detailing the whole manufacturing process of DOTA active pharmaceutical ingredient (API) in detail. Different forms of DOTA DMFs exist exist since differing nations have different regulations, such as DOTA USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A DOTA DMF submitted to regulatory agencies in the US is known as a USDMF. DOTA USDMF includes data on DOTA's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The DOTA USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of DOTA suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a DOTA Drug Master File in Korea (DOTA KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of DOTA. The MFDS reviews the DOTA KDMF as part of the drug registration process and uses the information provided in the DOTA KDMF to evaluate the safety and efficacy of the drug.
After submitting a DOTA KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their DOTA API can apply through the Korea Drug Master File (KDMF).
click here to find a list of DOTA suppliers with KDMF on PharmaCompass.
DOTA Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of DOTA GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right DOTA GMP manufacturer or DOTA GMP API supplier for your needs.
A DOTA CoA (Certificate of Analysis) is a formal document that attests to DOTA's compliance with DOTA specifications and serves as a tool for batch-level quality control.
DOTA CoA mostly includes findings from lab analyses of a specific batch. For each DOTA CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
DOTA may be tested according to a variety of international standards, such as European Pharmacopoeia (DOTA EP), DOTA JP (Japanese Pharmacopeia) and the US Pharmacopoeia (DOTA USP).
LOOKING FOR A SUPPLIER?
